Security Snapshot

RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) Institutional Ownership

CUSIP: 766559702

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

88

Shares (Excl. Options)

7.69MFull value: 7,686,814 · shares · 30 Sep 2026

Price

$48.15

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
RIGL on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
7,686,814
Latest holder snapshot 5 signals
Total 13F value
$370,584,818
Portfolio coverage rank
0%
Share change
+1,764,284
Value change
+$85,483,554
Number of holders
88
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
18,656,246
SEC-reported price per share
$48.15
Insider filing price
$48.15
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • RIGL - RIGEL PHARMACEUTICALS INC - Common Stock is tracked under CUSIP 766559702.
  • 88 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 154 to 88 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $640.47MFull value: $640,471,122 · USD · 30 Jun 2026
    to
    $370.58MFull value: $370,584,818 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 88 institutions filings for Q3 2026.

Open SEC evidence

Security key

766559702

13F reference period

Q3 2026

13F holders

88

13D/G owners

6

CIK / CUSIP context first

Open Q3 2026 holders RIGL full holder history RIGEL PHARMACEUTICALS INC SEC filings RIGEL PHARMACEUTICALS INC company facts RIGEL PHARMACEUTICALS INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
RIGL
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 9.9% +94% $76,136,715 +$36,153,855 1,843,504 +90% Soleus Capital Master Fund, L.P. 30 Jun 2026
ARMISTICE CAPITAL, LLC 9% +29% $69,053,600 +$16,189,600 1,672,000 +31% Armistice Capital, LLC 30 Jun 2026
BlackRock, Inc. 7.7% -22% $26,340,596 -$6,978,323 1,381,983 -21% BlackRock, Inc. 31 Mar 2025
MORGAN STANLEY 6.5% +580% $58,389,386 +$52,784,438 1,212,656 +942% Morgan Stanley 30 Sep 2026
STATE STREET CORP 4.7% -22% $42,365,355 -$10,177,032 879,862 -19% STATE STREET CORPORATION 30 Sep 2026
Invesco Ltd. 0% $122,918 6,449 Invesco Ltd. 31 Dec 2024
As of 30 Sep 2026, 88 institutional investors reported holding
7.69MFull value: 7,686,814 · shares · 30 Sep 2026
shares of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL). This represents 41% of the company’s total
18.66MFull value: 18,656,246 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
38%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 6.7% 1,256,819 +576% 0% $60,515,834
AMERICAN CENTURY COMPANIES INC 5.6% 1,043,966 +41% 0.02% $50,266,963
STATE STREET CORP 4.7% 879,862 -15% 0% $42,365,355
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 782,703 -0.31% 0% $37,687,149
Assenagon Asset Management S.A. 2.9% 535,685 0.03% $25,793,233
GEODE CAPITAL MANAGEMENT, LLC 2.6% 482,976 -0.04% 0% $23,260,958
MARSHALL WACE, LLP 2.2% 403,462 +9.8% 0.02% $19,426,698
CM Management, LLC 1.3% 250,000 0% 8.1% $12,037,500
VANGUARD PORTFOLIO MANAGEMENT LLC 1.1% 213,647 -8.6% 0% $10,287,103
FRANKLIN TEMPLETON INC 0.77% 144,038 +17% 0% $7,387,709
VANGUARD FIDUCIARY TRUST CO 0.66% 122,916 +0.97% 0% $5,918,405
RITHOLTZ WEALTH MANAGEMENT 0.58% 107,590 +14% 0.07% $5,180,459
DIMENSIONAL FUND ADVISORS LP 0.54% 100,717 -56% 0% $4,849,682
FIRST TRUST ADVISORS LP 0.53% 98,934 +22% 0% $4,763,672
Hennion & Walsh Asset Management, Inc. 0.49% 90,824 +3.4% 0.13% $4,373,176
Empowered Funds, LLC 0.46% 85,735 +8.3% 0.02% $4,128,140
CREDIT AGRICOLE S A 0.42% 78,164 +171% 0.01% $3,763,597
RENAISSANCE TECHNOLOGIES LLC 0.39% 73,119 -50% 0% $3,520,680
Lionhunter Capital Management, LLC 0.38% 70,045 +11% 1.5% $3,372,667
Universal- Beteiligungs- und Servicegesellschaft mbH 0.3% 56,578 +2.5% 0% $2,724,231
OMERS ADMINISTRATION Corp 0.28% 51,900 0% 0.02% $2,498,985
Virtus Investment Advisers, LLC 0.28% 51,309 +45% 0.55% $2,470,528
BURNEY CO/ 0.27% 50,851 -8.8% 0.07% $2,448,476
Sterling Capital Management LLC 0.24% 45,700 +12218% 0.04% $2,200,455
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 0.23% 43,818 +479% 0% $2,109,837

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Headline period
Q3 2026
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 7,686,814 $370,584,818 +$85,483,554 $48.15 88
2026 Q2 16,381,464 $640,471,122 +$30,231,860 $39.12 154
2026 Q1 15,986,079 $431,986,659 -$13,467,964 $27.04 149
2025 Q4 16,094,279 $688,576,820 +$63,536,235 $42.83 185
2025 Q3 14,989,035 $424,666,568 +$32,448,563 $28.33 164
2025 Q2 13,883,445 $260,032,689 +$336,299 $18.73 121
2025 Q1 13,902,025 $250,095,419 +$32,047,743 $17.99 118
2024 Q4 12,067,467 $202,977,408 +$2,514,731 $16.82 114
2024 Q3 11,904,852 $192,606,131 +$27,253,219 $16.18 87
2024 Q2 10,378,502 $85,309,593 +$85,148,446 $8.22 80
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .